Skip to main content

RedHill Biopharma Ltd.

RDHL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001553846

In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding RedHill Biopharma Ltd. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of RDHL: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders6455−9
Shares10.6M7.13M−3.45M (−32.6%)
Value$77.4M$49.1M−$28.3M (−36.6%)

New holders (8)

Institutions that held RedHill Biopharma Ltd. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to RDHL in Q2 2021
InstitutionSharesValue% of portfolio
ACT Capital Management, LLC140,000$964.0K0.50%
Jefferies Group LLC40,000$275.2K0.00%
Simplex Trading, LLC27,732$190.0K0.01%
Jane Street Group, LLC20,725$142.0K0.00%
Renaissance Technologies LLC19,879$137.0K0.00%
Jump Financial, LLC14,700$101.0K0.01%
CIBC World Markets Inc.11,075$76.0K0.00%
Spire Wealth Management200$1.00K0.00%

Sold out (17)

Institutions that held RedHill Biopharma Ltd. at the end of Q1 2021 and filed for Q2 2021 without it.